Post-translational protein arginylation is essential for cardiovascular development and angiogenesis in mice and is mediated by arginyl-transfer RNA-protein transferases Ate1-a functionally conserved but poorly understood class of enzymes. Here, we used sequence analysis to detect the evolutionary relationship between the Ate1 family and bacterial FemABX family of aminoacyl-tRNApeptide transferases, and to predict the functionally important residues in arginyltransferases, which were then used to construct a panel of mutants for further molecular dissection of mouse Ate1. Point mutations of the residues in the predicted regions of functional importance resulted in changes in enzymatic activity, including complete inactivation of mouse Ate1; other mutations altered its substrate specificity. Our results provide the first insights into the mechanisms of Ate1-mediated arginyl transfer reaction and substrate recognition, and define a new protein superfamily called Dupli-GNAT to reflect its origin by the duplication of the GNAT acetyltransferase domain.
INTRODUCTION
Arginyltransferases (R-transferases or Ate1; EC 2.3.2.8) are found in the eukaryotes and in many bacteria (Balzi et al, 1990; Kwon et al, 1999; Rai & Kashina, 2005;  supplementary Fig 1 online) . These enzymes transfer arginine from charged transfer RNA-Arg to amino-terminally exposed residues of their protein substrates (Gonda et al, 1989) . Arginylation decreases the stability of some proteins and induces their degradation by the N-end rule pathway (Bachmair et al, 1986) . R-transferase gene Ate1 is non-essential in yeast Saccharomyces cerevisiae, whereas its mammalian orthologue is essential for cardiovascular development and angiogenesis in mice (Kwon et al, 2002) . Unlike the intronless yeast transcript, the product of Ate1 in the mouse undergoes alternative splicing to produce four protein forms with different activity, substrate specificity, tissue expression and intracellular localization (Kwon et al, 1999; Rai & Kashina, 2005) .
In addition to R-transferases, there are other known classes of enzymes with aminoacyl-tRNA-protein transferase activity. One such class is the Leu/Phe-tRNA-protein transferases (L/F-transferases; Leibowitz & Soffer, 1970 ). Yet another class of aminoacyltRNA-protein transferases includes the bacterial low-affinity penicillin-binding proteins, also known as methicillin resistance proteins. These enzymes use aminoacyl-tRNA cofactor, typically charged with Gly or Ala, to form interchain peptide linkers and to attach them to L-lysine in the linear pentapeptide-disaccharide chains of peptidoglycan (Mallorqui-Fernandez et al, 2004) . Crystal structures of several enzymes of this family, including FemA from Staphylococcus aureus and FemX from Weissella viridescens, have been determined (Benson et al, 2002; Biarrotte-Sorin et al, 2004) . The enzyme consists of two domains with similar threedimensional folding, which bears striking resemblance to acetyltransferases from the GNAT family (Neuwald & Landsman, 1997) . The N-acetyltransferase reaction catalysed by GNATs is mechanistically similar to attaching an amino acid to the N terminus of a peptide, although, as a rule, GNATs use acyl-coenzyme A, rather than aminoacylated tRNA, as the acyl group donor.
Unlike bacterial FemABX, R-transferases are found in all eukaryotes and in many bacteria ( supplementary Fig 1 online) . Although all R-transferases share a set of conserved sequence elements, there is substantial sequence divergence within the family, as well as insertions in several regions of the protein, especially in eukaryotic homologues (see below). Three Cys residues, located close to the N terminus, are important for yeast Ate1 activity (Li & Pickart, 1995) and deletion of the portion of Ate1 encoded by the first exon of the mouse gene results in the loss of its ability to induce degradation of model substrates in yeast (Kwon et al, 1999) . The alternative splicing of the N-terminal exon results in marked differences in substrate specificity: mouse Ate1 forms containing exon 2 of the Ate1 gene can arginylate protein substrates with N-terminal Asp, Glu and Cys, whereas exon 1 renders mouse Ate1 unable to arginylate Asp-and Glu-containing substrates (Rai & Kashina, 2005) . Beyond these observations, very little is known about the structure, function and evolution of R-transferases.
Here, we show that Ate1 and FemABX families of tRNA-protein transferases have related sequences, probably inherited from a common ancestor, and might adopt similar structure. Site-directed mutagenesis of conserved amino-acid residues results in changes in Ate1 activity and substrate specificity. Our results establish a new protein superfamily, called Dupli-GNAT to reflect its likely origin by the duplication of the GNAT acetyltransferase domain, and provide new insights into the evolution, structure and function of Ate1, suggesting possible mechanisms of arginyl transfer reaction and substrate recognition.
RESULTS

Analysis of aminoacyl-tRNA-protein transferases
To identify relatives of Ate1, we searched the non-redundant protein sequence database at NCBI using sensitive sequence comparison methods. We found that the R-transferase (Ate1) and L/F-transferase (Aat) families, previously thought to be unrelated to each other, are evolutionarily related and form a superfamily with methicillin resistance proteins FemABX and many uncharacterized proteins, mostly from bacteria. All these proteins contain carboxy-terminal domain with GNAT-like acetyltransferase fold, which seems to bear most of the determinants of the catalytic activity (see below). Several proteins with established acetyltransferase activity and GNAT fold were also retrieved in our search with high statistical significance. The alignment with the known GNATs was confined to the C-terminal halves of the longer Ate1, Aat and FemABX sequences.
To extend the results of the database search and fold recognition, and to study sequence-structure-function relationships in FemABX and Ate1 families in more detail, we constructed a multiple sequence alignment (Fig 1; supplementary Fig 1  online) , and compared it with the known three-dimensional structures of the FemABX enzymes.
All the known FemABX enzymes consist of two GNAT folds, one inserted into the other (which makes the designation of the N-and C-terminal domains inaccurate, because the 'N-terminal' GNAT fold in fact contains two short strands and a helix contributed by the C-terminal tip of the protein sequence). The core of the GNAT fold is a three-layer aba structure, with the mixed b-sheet between two pairs of a-helices. These helices and strands are conserved in the C-terminal halves of R-transferases. The conservation goes beyond the similar arrangement of the secondary structure elements, and is clearly seen at the sequence level (Fig 1; supplementary Fig 1 online) . In particular, Ate1 and FemABX protein families share an array of highly conserved, bulky hydrophobic (and often aromatic) residues in helices 8, 9 and 10, and in strand 10 (numbering is from the Protein Data Bank (PDB) structure 1P4N), including a well-conserved dipeptide in helix 10, which consists of an aromatic and a positively charged residue (F304/K305 in FemX, corresponding to Y416/K417 in mouse Ate1-1). These amino acids may have a role in cofactor binding and/or catalysis.
Examination of the known three-dimensional structures of Wajira virescens FemX protein in free form and in complex with ) provides functional interpretation to these conserved sequence features and a better prediction of the Ate1 activity determinants. The UDP-MurNAc pentapeptide is bound to the W. virescens FemX in a groove between the N-and C-terminal domains, and most of the direct contacts between the protein and the substrate are provided by the solvent-exposed surface of the N-terminus. The only place on the molecule that would be able to accommodate the aminoacylated 3 0 end of tRNA is the cleft produced by a bulge in the middle of two parallel strands in the C-terminal GNAT fold that pushes the distal ends of these strands apart from each other and from the adjoining a-layer.
The crystal structure of L/F-transferase (Aat) from Escherichia coli has been deposited in the PDB (PDB ID 2CXA). In full agreement with the conservation between C-terminal halves of the Aat and Ate1 family, the C-terminal half of Aat matches the GNAT-like folds with high significance (see supplementary information online). The N-terminal portion of Aat, however, has an abbreviated a þ b structure, with only one layer of helices and with shorter strands. Thus, a trend in the evolution of tRNAdependent aminoacyl transferase structure seems to be the duplication of the GNAT domain followed by constrained evolution of the catalytic C-terminal copy and a more rapid divergence of the substrate-binding N-terminal copy.
Identification of targets for site-directed mutagenesis
To probe the putative cofactor-binding site more directly, we used the arginylated CCA end of a tRNA and the high-resolution structure of FemX (PDB ID 1P4N) to perform computational docking experiments, seeking the most likely structure of a putative complex between FemX and CCA-Arg. Although this fragment represents a non-cognate substrate of FemX, the analysis of the complex provided further insights into the structural features required for the activity of FemABX and Ate1 enzymes (Fig 2) .
The minimum free energy was given by the CCA-Arg moiety docked to the crevice in the C-terminal domain, as has been also predicted for the cognate cofactor (Biarrotte-Sorin et al, 2004) . The depth of the crevice in FemX is more than sufficient to accommodate the large side chain of the non-cognate arginine, but the tRNA seems to be stopped by steric hindrance, and possible repulsion, between the base of the adenine and the aromatic ring of F304 (Y416 in mouse Ate1). Another highly conserved aromatic residue, Y254 (F313 in mouse Ate1), seems to be in direct contact with the a-carbon atom of Arg in our model. These two residues tentatively identify the determinants of tRNA positioning in the active centre. The side chain of the only universally conserved, positively charged residue in the whole alignment, K307/K417, points in the direction of the peptide substrate. We suggest that this residue has a direct role in catalysis. As a control, we have also mutagenized a nearby lysine residue, K413 of mouse Ate1, which is likely to point into the solution and is replaced by tyrosine in FemX.
Several features of the multiple alignment attracted our attention for a complementary reason, especially notable patterns of family-specific or isoform-specific conservation. One such feature at the rim of the putative cofactor-binding crevice is conserved in the Ate1 but not in FemABX enzymes: at the end of strand 10, Ate1 family has a highly conserved proline residue (P370), which is expected to produce a tight kink at the entrance to the putative active centre of the enzyme and is the closest residue to the conjugated 2 0 OH atom of the last adenine in the 3 0 end of tRNA; this 'proline shoulder' is missing in FemX.
In the N-terminal domain of Ate1, sequence conservation patterns are complicated by the alternative exon usage. Among the four mammalian Ate1 forms, mouse Ate1-1 and Ate1-2 are able to arginylate all known types of substrate, whereas mouse Ate1-3 and Ate1-4 are apparently specific for the N-terminal Cys Molecular dissection of arginyltransferases R. Rai et al (Rai & Kashina, 2005) . These forms differ by a homologous N-terminal stretch of B30 amino-acid residues, suggesting that the determinants that confer this difference in substrate specificity may be located within this stretch. Comparison of Ate1 forms from warm-blooded vertebrates (Fig 3) indicates that the site with the largest degree of chemical dissimilarity between the broadspecificity and narrow-specificity groups is the stretch of amino acids 8-10 (as counted in the mouse Ate1-3 sequence). We speculated that these residues might be potential determinants of substrate specificity.
Analysis of the targeted substitutions in Ate1 in vivo
To test the predictions described above, we performed point mutagenesis of mouse Ate1-1-the most active form of mouse Ate1, which has universal substrate specificity. The standard in vivo assay exploits the effect of Ate1 on the rate of protein degradation of test substrates in yeast. Proteins containing N-terminal Arg are extremely short-lived in S. cerevisiae, and Ate1 can therefore induce rapid degradation of a test substrate (b-galactosidase or b-Gal) containing arginylatable N-terminal residues. Mammalian Ate1 forms are able to complement ate1D strains of S. cerevisiae and induce degradation of b-Gal derivatives containing N-terminally exposed Asp or Glu, which are otherwise stable in this strain of yeast (Bachmair et al, 1986 ). We applied this complementation assay to the mammalian Ate1-1 derivatives containing point mutations. The results of this experiment are presented in Fig 4 and Table 1 . In agreement with our prediction, the K417A mutation reduced mouse Ate1-1 activity to the levels undetectable by our assay. This result indicates that the universally conserved, positively charged residue in that position is crucial for Ate1 activity.
Interestingly, other mutants had various changes in arginylation activity and, in some cases, differential effects on Asp-versus Glucontaining substrates. F313A mutation slightly decreased mouse Ate1 activity, which suggested that despite the conservation of the aromatic residue, this site is at best a secondary determinant of cofactor recognition. In contrast, changing the main-chainbending amino acid P370 into more flexible A residue, which should result in the relaxation of the proline shoulder, enhanced mouse Ate1 activity, especially on the Asp-containing substrate. This gain of activity, however, was reversed by replacing two aspartic acid residues flanking P370 and, in addition, the activity of the DPD-AAA mutant towards the glutamate-containing substrate was significantly reduced compared with the control. Thus, negative charge at the rim of the putative cofactor-binding crevice seems to be required for enzymatic activity. Replacement of Y416A in the depth of the cofactor-binding crevice had virtually no effect on the degradation of Asp-containing substrate, but affected the Glu-containing substrate (Fig 4A; Table 1) .
Substitution of the three-amino-acid stretch in the positions 8-10 (KGL) of Cys-specific mouse Ate1-3 with the FEG stretch found in the corresponding positions of Ate1-1 (positions 15-17) resulted in Ate1-3 gaining the ability to induce degradation of Asp-and Glu-containing substrates (Fig 4B; Table 1 ), indicating that this amino-acid stretch, in agreement with predictions, is indeed important for the differential substrate specificity of Ate1 forms. Error bars represent standard deviation for each data set, which consisted of 7-15 independent measurements. Colours correspond to the measurements for each mouse Ate1 mutant as noted to the right of the graph. Activity changes for mouse Ate1 mutants are reported in Table 1 as percentages of the b-Gal activity in the presence of wild-type or mutant Ate1-1 and Ate1-3 and difference between the inversed percentages for mutant Ate1 and the corresponding wild-type controls.
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DISCUSSION
This study demonstrates sequence and structural similarity between R-transferases, L/F-transferases and bacterial FemABX tRNA-dependent aminoacyl-peptide transferases. A mechanistic analogy between non-ribosomal peptide synthases involved in methicillin resistance and aminoacyl-tRNA-protein transferases has been suggested before (Hegde & Shrader, 2001 ), but no sequence similarity between these enzymes has been previously found. All the identified Ate1 homologues consist of two domains, apparently evolved by duplication and subsequent divergence of the GNAT-like acetyltransferase domain. The C-terminal, catalytic domain, is predicted to bind the charged tRNA. The N-terminal domain, while maintaining characteristic GNAT-like fold, has lost its cofactor-binding role and, in the case of the L/F-transferase, has been structurally remodelled. We propose to call this newly identified superfamily of proteins Dupli-GNAT, to reflect their likely evolutionary emergence by the duplication of the GNATlike domain.
In the course of sequence database searches, we observed other significant sequence similarities between members of the Dupli-GNAT superfamily and proteins with other known or unknown activities ( supplementary Fig 2 online) . Many of these proteins were found in fusions with other domains. The emerging picture of these and other protein fusions indicates that nonribosomal transfer of an amino acid from charged tRNA to various substrates by Dupli-GNAT proteins might be a widespread strategy of biosynthesis and regulation in bacteria and eukaryotes. In R-transferases, which are the subject of this study, the basic Dupli-GNAT architecture is observed in the bacterial representatives, but is typically elaborated by insertions in the eukaryotic Ate1 homologues. Most of the eukaryotic Ate1 sequences are predicted gene products, but some of the extra sequences are conserved across many eukaryotes and we believe that they represent genuine insertions ( supplementary Fig 1 online) .
Dupli-GNAT proteins are widespread among bacteria, are mostly represented by Ate1 family in eukaryotes and are missing from the Archaea. This is compatible with an evolutionary model in which an ancestral enzyme has emerged by duplication of the ancient GNAT fold and was adapted to using tRNA instead of acetyl-CoA as the donor of an acyl group. The ancestral function of Dupli-GNATs was probably in membrane modification and peptidoglycan biosynthesis. Diversification of this fold produced R-transferases and L/F-transferases-most probably in the Proteobacteria, in which both these families are widespread today. From Proteobacteria, R-transferases may have been disseminated by horizontal transfer into a few other bacteria and by symbiogenesis to eukaryotes.
Guided by sequence comparison and structural modelling, we mutated several putative determinants of Ate1 structure and function. In an in vivo complementation assay, most of our Fig 4) . Together with the fact that some of these mutants show increased activity, this strongly argues that the point mutations did not cause general destabilization of the protein conformation. The same observations, together with earlier results on differential substrate specificity of the alternatively spliced mouse Ate1 forms (Rai & Kashina, 2005) , also suggest that the activity and substrate specificity of the wild-type Ate1 are in an exquisite balance, which is enabled by many molecular determinants dispersed across the molecule. The phenotypes of the mutants suggest several lines of future investigation. Subsets of targets of Ate1 may now be isolated using the mutants that show preference towards different residues at the N terminus of the substrate protein. Mutant forms with increased or reduced activity and specificity should be useful for structural studies of R-transferase activity. Finally, our results on the identification of specific functionally important amino-acid residues based on the homology between Ate1 and FemABX should provide better understanding of the catalytic mechanism of bacterial enzymes of peptidoglycan biosynthesis, which are promising targets of new antibiotic development.
METHODS
Sequence analysis. Sequence similarity searches were performed with the BLAST family of programs (Altschul et al, 1997) and using the HHSearch server (Soding, 2005) ; homologous sequences were aligned using MUSCLE (Edgar, 2004) . Docking was performed using the GRAMM program v 1.03 (Vakser, 1996) . The results of the computational analysis are described in more detail in the supplementary information online. Ate1 yeast complementation assay. Yeast wild type and ate1D mutants were co-transformed with plasmids carrying mouse Ate1-1, Ate1-3, or their mutant derivatives (see the supplementary information online for mutant construction details), and Ub-XbGal protein substrates in high copy number pUB23-X plasmids expressing Ub-X-bGal proteins from PGAL promoter as described by Bachmair et al (1986) , where X represents the N-terminal amino acid of the b-Gal substrate. In this study, we used plasmids encoding Ub-M, D, E, R-bGal. Protein expression was induced by 1% galactose and b-Gal activity was measured using ONPG liquid assay as described by Kwon et al (1999) .
